ESR1 and breast cancer: We used a phenol-red free DMEM medium containing 5% FBS so that the background estrogen level is in a range that is unlikely to induce adaptive changes due to estrogen deprivation and to minimize the agonistic action of tamoxifen in ER(+) breast cancer cells.